Biotechnology Stocks I: Returns for Keros Therapeutics, Inc. (KROS)
KROS has no dividends.
Table and Chart of KROS Performance
See what a $1,000 investment in KROS is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| KROS Returns | |
|---|---|
| Start Date | May-29-2020 |
| Start Price | $28.74 |
| End Date | Dec-05-2024 |
| End Price | $64.61 |
| # Prices | 56 |
| Min Date | Jun-30-2022 |
| Min Price | $27.63 |
| Max Date | Nov-30-2020 |
| Max Price | $75.61 |
| Total Return | 124.81% |
| Annualized Return | 18.96% |
| Current Value of $1,000 Purchase | $2,248 |
| Number Returns | 1,540 |
| Average Return | 8.84% |
| Number Profitable Returns | 792 |
| Percent Profitable Returns | 51.43% |
| Number Unprofitable Returns | 748 |
| Percent Unprofitable Returns | 48.57% |
| Profitable to Unprofitable Returns Ratio | 1.06 |
| KROS Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,024 |
| Beta | -13.050 | Price to Sales | 0.00 |
| Earnings per Share | $0.0000 |
| PE Ratio | -202890000 |
| PE to Growth Ratio | None |
| Price to Book | 4218.12 |
| PRICE DATA | |
| 52 Week High | $1.236 |
| 52 Week Low | $73 |
| Analyst Target Price | $47.5 |
| 50-Day Moving Average | $27.31 |
| 200-Day Moving Average | $59.61 |
| FINANCIAL DATA | |
| Revenue per Share | $-5.68 |
| Revenue | $0 |
| Profit Margin | 1.9% |
| Return on Equity | -28.2% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
KROS Compare Returns with S&P 500
KROS Trendline Chart
KROS Moving Average Chart
KROS Stock Return Map - See Patterns of Gains and Losses
KROS Stock Returns/Purchase Dates